pdc-apb
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02700373)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pdc-apb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04853823 | Phase 1 | Nov 1, 2021 | Hapten Sciences, Inc., Pennsylvania State University |
| NCT02700373 | Phase 1 | Mar 1, 2016 | Clinical Research Solutions, Hapten Sciences, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hapten Sciences, Inc. | For profit | 2 | 2 | 1 | 2016 |
| Clinical Research Solutions | For profit | 1 | 0 | 1 | 2016 |
| Pennsylvania State University | Academic/Hospital | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1